Cytomid 250 mg is a notable pharmaceutical product that serves as an effective treatment for certain medical conditions. It is manufactured by Cipla Ltd, a renowned pharmaceutical company known for producing high-quality medications. Cytomid 250 mg contains a potent active ingredient called Flutamide, which is utilized to address specific health concerns.
Anti Androgen
Cytomid 250 mg
Generic For Drogenil
Generic Name Flutamide
Add to WishlistRemove from Wishlist
Add to Wishlist
Ingredient
Each tablet of Cytomid 250 mg contains Flutamide, a non-steroidal anti-androgen compound. Flutamide works by competitively blocking the effects of male hormones (androgens) in the body, particularly testosterone. This mechanism of action makes it a valuable medication in the management of certain conditions.
Usage
Cytomid 250 mg is primarily prescribed for the treatment of advanced prostate cancer. Prostate cancer is often fueled by the presence of androgens, such as testosterone, which contribute to the growth and spread of cancer cells. By inhibiting the action of androgens, Flutamide helps slow down the progression of the disease and manage its symptoms.
This medication is typically part of a comprehensive treatment plan that may involve other medications or therapies. It is important to follow the prescribed dosage and instructions provided by a healthcare professional for optimal results.
It’s crucial to strictly adhere to the prescribed dosage and usage instructions provided by your doctor or healthcare provider. Cytomid 250 mg tablets should be taken orally, usually with or without food. Ensure you read the label and any accompanying patient information leaflet before using the medication. Please note that Cytomid 250 mg is a prescription medication, and its usage should be under the supervision and guidance of a qualified medical professional.
Manufacturer
Cytomid 250 mg is manufactured by Cipla Ltd, a reputable pharmaceutical company known for its commitment to producing high-quality and effective medications. Cipla Ltd has a history of providing innovative healthcare solutions and contributing to improving patients’ quality of life.
In conclusion, Cytomid 250 mg, with its active ingredient Flutamide, offers a valuable treatment option for advanced prostate cancer. Manufactured by Cipla Ltd, this medication underscores the importance of precision pharmacology in addressing specific medical conditions. As always, consult your healthcare provider for comprehensive information, proper usage, and guidance on Cytomid 250 mg.
Reviews
There are no reviews yet.